The 2023 Intergenerational Report has reaffirmed the longstanding government view of investment in new therapeutic technologies as a 'cost' and that it will be the biggest driver of rising health costs.
IGR reinforces the isolation of health spending as a 'cost' to be managed
August 25, 2023 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Montu pushes for national standards at Productivity Commission inquiry
June 17, 2025 - - Latest News -
Canadian appointed to lead New Zealand's Pharmac
June 17, 2025 - - Latest News -
US FDA approves CSL's treatment for hereditary angioedema
June 17, 2025 - - Latest News -
Australia's system is more uniform than the US, but not uniformly better
June 17, 2025 - - Latest News -
Australian company secures FDA approval to progress development of CAR-T therapy
June 16, 2025 - - Latest News -
These systems are and always have been more similar than most realise
June 16, 2025 - - Latest News -
Confirmation the UK has agreed to review medicine prices in response to US demand
June 16, 2025 - - Latest News